We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction: Yagolovich et al. DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma. Int. J. Mol. Sci. 2022, 23 , 12687.
- Authors
Yagolovich, Anne V.; Isakova, Alina A.; Artykov, Artem A.; Vorontsova, Yekaterina V.; Mazur, Diana V.; Antipova, Nadezhda V.; Pavlyukov, Marat S.; Shakhparonov, Mikhail I.; Gileva, Anastasia M.; Markvicheva, Elena A.; Plotnikova, Ekaterina A.; Pankratov, Andrey A.; Kirpichnikov, Mikhail P.; Gasparian, Marine E.; Dolgikh, Dmitry A.
- Abstract
This document is a correction notice for an article titled "DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma." The correction addresses a mistake in Figure 4D of the original publication, where an image was accidentally replaced. However, the error does not significantly impact the results, as the lack of cytotoxicity of a certain concentration of DR5-B is confirmed by viability data. The conflicts of interest statement in the original publication is also clarified. The authors apologize for any confusion caused.
- Subjects
PEPTIDES; ANTINEOPLASTIC agents; GLIOBLASTOMA multiforme; NONLINEAR regression; CYTOTOXINS
- Publication
International Journal of Molecular Sciences, 2024, Vol 25, Issue 10, p5334
- ISSN
1661-6596
- Publication type
Correction Notice
- DOI
10.3390/ijms25105334